140 related articles for article (PubMed ID: 37211822)
1. Global status of phenotypic pyrazinamide resistance in
Wang Z; Tang Z; Heidari H; Molaeipour L; Ghanavati R; Kazemian H; Koohsar F; Kouhsari E
J Chemother; 2023 Nov; 35(7):583-595. PubMed ID: 37211822
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China.
Che Y; Bo D; Lin X; Chen T; He T; Lin Y
BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989
[TBL] [Abstract][Full Text] [Related]
4. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM
BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808
[TBL] [Abstract][Full Text] [Related]
5. Pyrazinamide Susceptibility and
Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence and transmission of pyrazinamide-resistant
Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
[No Abstract] [Full Text] [Related]
7. Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China.
Li D; Hu Y; Werngren J; Mansjö M; Zheng X; Drobniewski F; Hoffner S; Xu B
Antimicrob Agents Chemother; 2016 Sep; 60(9):5159-66. PubMed ID: 27297481
[TBL] [Abstract][Full Text] [Related]
8. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK
BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572
[TBL] [Abstract][Full Text] [Related]
9. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
[TBL] [Abstract][Full Text] [Related]
10. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.
Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A
BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Hangzhou, China.
Liu W; Chen J; Shen Y; Jin J; Wu J; Sun F; Wu Y; Xie L; Zhang Y; Zhang W
Clin Microbiol Infect; 2018 Sep; 24(9):1016.e1-1016.e5. PubMed ID: 29288021
[TBL] [Abstract][Full Text] [Related]
12. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
[TBL] [Abstract][Full Text] [Related]
13. Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan.
Huang HT; Lin WH; Chan TH; Jou R
J Microbiol Immunol Infect; 2023 Dec; 56(6):1236-1244. PubMed ID: 37690869
[TBL] [Abstract][Full Text] [Related]
14. Resistance to pyrazinamide in Russian Mycobacterium tuberculosis isolates: pncA sequencing versus Bactec MGIT 960.
Maslov DA; Zaĭchikova MV; Chernousova LN; Shur KV; Bekker OB; Smirnova TG; Larionova EE; Andreevskaya SN; Zhang Y; Danilenko VN
Tuberculosis (Edinb); 2015 Sep; 95(5):608-12. PubMed ID: 26071666
[TBL] [Abstract][Full Text] [Related]
15. A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.
Whitfield MG; Soeters HM; Warren RM; York T; Sampson SL; Streicher EM; van Helden PD; van Rie A
PLoS One; 2015; 10(7):e0133869. PubMed ID: 26218737
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pyrazinamide resistance in consecutive multidrug-resistant
Mansjo M; Werngren J; Hoffner S
Int J Mycobacteriol; 2017; 6(2):156-161. PubMed ID: 28559517
[TBL] [Abstract][Full Text] [Related]
17. pncA gene mutations in reporting pyrazinamide resistance among the MDR-TB suspects.
Wu X; Lu W; Shao Y; Song H; Li G; Li Y; Zhu L; Chen C
Infect Genet Evol; 2019 Aug; 72():147-150. PubMed ID: 30447296
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China.
Xu P; Wu J; Yang C; Luo T; Shen X; Zhang Y; Nsofor CA; Zhu G; Gicquel B; Gao Q
Tuberculosis (Edinb); 2016 May; 98():56-61. PubMed ID: 27156619
[TBL] [Abstract][Full Text] [Related]
19. Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis.
Kuhlin J; Davies Forsman L; Mansjö M; Jonsson Nordvall M; Wijkander M; Wagrell C; Jonsson J; Groenheit R; Werngren J; Schön T; Bruchfeld J
Clin Infect Dis; 2021 Nov; 73(9):e3511-e3517. PubMed ID: 33011791
[TBL] [Abstract][Full Text] [Related]
20. Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study.
Sun F; Li Y; Chen Y; Guan W; Jiang X; Wang X; Ren P; Li J; Shi J; He G; Wu M; Tang P; Wang F; Sheng Y; Huang F; Zhou Z; Huang H; Hong L; Liu Q; Zhang Y; Zhang W
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30578402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]